Search research articles
Contact Us
Filters
Showing results (71-80 of 118) with videos related to
Page
of 12
Sort By:
Histochemistry and Cell Biology
|
May 11, 2020
Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer
Susanne Beyer, Fangfang Chen, Sarah Meister, et al.
Archives of Gynecology and Obstetrics
|
December 6, 2021
The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
Fangfang Chen, Thomas Kolben, Sarah Meister, et al.
Scientific Reports
|
February 4, 2022
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Susann Badmann, Doris Mayr, Elisa Schmoeckel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
Journal of Cancer Research and Clinical Oncology
|
June 21, 2022
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Thomas Kolben, Lena Müller, Sarah Meister, et al.
Cancers
|
August 29, 2019
Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
Katharina Dötzer, Friederike Schlüter, Markus Bo Schoenberg, et al.
British Journal of Clinical Pharmacology
|
June 3, 2015
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients
Hagen Sjard Bachmann, Werner Meier, Andreas du Bois, et al.
Cells
|
September 28, 2021
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
Eileen Deuster, Ivi Hysenaj, Maja Kahaly, et al.
Frontiers in Oncology
|
October 11, 2021
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
Nicole Elisabeth Topalov, Doris Mayr, Clemens Scherer, et al.
Biomedicines
|
July 2, 2021
Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
Yue Liao, Susann Badmann, Till Kaltofen, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 118) with videos related to
Sort By:
Page
of 12
Histochemistry and Cell Biology
|
May 11, 2020
Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer
Susanne Beyer, Fangfang Chen, Sarah Meister, et al.
Archives of Gynecology and Obstetrics
|
December 6, 2021
The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
Fangfang Chen, Thomas Kolben, Sarah Meister, et al.
Scientific Reports
|
February 4, 2022
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Susann Badmann, Doris Mayr, Elisa Schmoeckel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
Journal of Cancer Research and Clinical Oncology
|
June 21, 2022
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
Thomas Kolben, Lena Müller, Sarah Meister, et al.
Cancers
|
August 29, 2019
Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
Katharina Dötzer, Friederike Schlüter, Markus Bo Schoenberg, et al.
British Journal of Clinical Pharmacology
|
June 3, 2015
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients
Hagen Sjard Bachmann, Werner Meier, Andreas du Bois, et al.
Cells
|
September 28, 2021
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
Eileen Deuster, Ivi Hysenaj, Maja Kahaly, et al.
Frontiers in Oncology
|
October 11, 2021
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
Nicole Elisabeth Topalov, Doris Mayr, Clemens Scherer, et al.
Biomedicines
|
July 2, 2021
Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
Yue Liao, Susann Badmann, Till Kaltofen, et al.
Page
of 12